Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy.
about
Arterial Therapies of Non-Colorectal Liver MetastasesTransarterial embolization therapies for the treatment of hepatocellular carcinoma: CEPO review and clinical recommendationsDoxorubicin-loaded drug-eluting beads versus conventional transarterial chemoembolization for nonresectable hepatocellular carcinomaTransarterial hepatic chemoembolization with 70-150 µm drug-eluting beads: assessment of clinical safety and liver toxicity profileLocoregional Therapy for Hepatocellular Carcinoma with and without Extrahepatic SpreadThe Safety and Clinical Outcomes of Chemoembolization in Child-Pugh Class C Patients with Hepatocellular Carcinomas.Effectiveness of Initial Transarterial Chemoembolization for Hepatocellular Carcinoma Among Medicare BeneficiariesRandomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres AloneChemoembolization and radioembolization for hepatocellular carcinoma.Efficacy of TACE in TIPS patients: comparison of treatment response to chemoembolization for hepatocellular carcinoma in patients with and without a transjugular intrahepatic portosystemic shunt.The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinoma.Intraarterial therapies for primary liver cancer: state of the art.Repeated intra-arterial therapy via the cystic artery for hepatocellular carcinoma.Risk of liver abscess formation in patients with prior biliary intervention following yttrium-90 radioembolization.Transarterial Chemoembolization for Hepatocellular Carcinomas with Central Bile Duct Invasion: Safety, Prognosis, and Predictive Factors.All-trans retinoic acid protects hepatocellular carcinoma cells against serum-starvation-induced cell death by upregulating collagen 8A2.Hepatocellular carcinoma rupture following transarterial chemoembolization.Contrast-enhanced ultrasound evaluation of residual blood flow to hepatocellular carcinoma after treatment with transarterial chemoembolization using drug-eluting beads: a prospective study.Bland Liver Tumor Embolization Complicated by Hepatic AbscessTreatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion.Hepatic imaging following intra-arterial embolotherapy.Transarterial embolization/chemoembolization therapy for hepatocellular carcinoma fed by adrenal artery: Preliminary results.Post-procedural Care in Interventional Radiology: What Every Interventional Radiologist Should Know-Part I: Standard Post-procedural Instructions and Follow-Up Care.Decision Making for Selection of Transarterial Locoregional Therapy of Metastatic Neuroendocrine Tumors.Post-procedural Care in Interventional Radiology: What Every Interventional Radiologist Should Know-Part II: Catheter Care and Management of Common Systemic Post-procedural Complications.The clinical application of 320-detector row CT in transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma.In situ gelling silk-elastinlike protein polymer for transarterial chemoembolization.Real-Life Report on Chemoembolization Using DEBIRI for Liver Metastases from Colorectal Cancer.Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.Therapeutic effects of transarterial infusion of lipiodol and ethanol in various ratios in a rabbit VX2 tumor modelChemoembolization for hepatocellular carcinoma fed by right internal thoracic artery.Risks factors for severe pain after selective liver transarterial chemoembolization.Pretransplant Intra-arterial Liver-Directed Therapy Does Not Increase the Risk of Hepatic Arterial Complications in Liver Transplantation: A Single-Center 10-Year Experience.Iterative reconstruction: comparison of techniques for reduced-dose liver computed tomography following transarterial chemoembolization for hepatocellular carcinoma.Prognostic factors of hepatocellular carcinoma patients with portal vein tumor thrombosis treated with transcatheter arterial chemoembolization.Pharmacokinetics, Safety, and Efficacy of Chemoembolization with Doxorubicin-Loaded Tightly Calibrated Small Microspheres in Patients with Hepatocellular Carcinoma.Transarterial Chemoembolization of Liver Metastases from Uveal Melanoma Using Irinotecan-Loaded Beads: Treatment Response and Complications.Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysis.Early Stage Hepatocellular Carcinomas Not Feasible for Ultrasound-Guided Radiofrequency Ablation: Comparison of Transarterial Chemoembolization Alone and Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation.Contrast-enhanced ultrasound identifies early extrahepatic collateral contributing to residual hepatocellular tumor viability after transarterial chemoembolization.
P2860
Q26764990-54AF0AB1-A5D1-4100-9E30-F51F33DB7F1BQ34702094-B0E006D0-BFA7-47FF-8C70-020814A9C173Q35682000-ABF37486-9701-4A17-9A5D-5C7D6C66A476Q35795014-F5D8772A-6D8C-431C-ADCD-170EF77FC409Q35951070-51E0FA1D-0F0B-49DE-BF04-FEF8AC81E594Q36279864-9C6D5644-0DAB-4EBD-A66B-CC49CBF026CAQ36886453-6A7AEE23-5D1E-4113-B97B-945BF8B1DCCFQ37138263-F71F15F6-ACF3-4146-A4D9-C2F9F8E6E0FCQ37238192-E880B8CD-2453-487E-86AC-3E727CA32B16Q37408313-CEA2FEBF-4CB6-4BF7-891C-2BC4DC4C24EBQ37606177-109055E2-8B65-458D-B7E7-DB291EAA8F2FQ38149993-797556D3-FDB2-404B-B11E-02EB0CA2ACD0Q38165802-27FFAC8E-4918-4C66-A034-05A58E69A384Q38225694-DEDA9DE9-341C-40BE-B9D3-43CE3257FF2FQ38281294-EDE9897D-65CD-4797-8456-6C7AE9D3A58AQ38318720-8E0AD7C5-B956-400C-BEFC-708B30DE20C1Q38374674-CFD2C9C2-1E7B-4431-ACBB-4575ABDF1722Q38441813-CBD37DAF-7383-4381-8957-0C67BE733059Q38578113-DA8F844A-9893-4409-9DFA-0FF389FBD0FAQ38590448-9E721B87-DB9C-42BB-A6D7-8C7E55DC3E21Q38716483-5E2CB81B-8D43-4EC0-ADB8-7C1404FA61B3Q39053284-668499AE-AE02-4FB5-B6C3-36AAB3F5B6A4Q39081080-92B3DB94-1FC2-45E8-85DA-8F10BD5717C0Q39349632-C4055A38-A78A-4784-91C1-5780C75FA77BQ39353588-FF8445A1-262D-43F4-A564-3B00430A26E7Q40258284-5C9781AB-391F-4CFF-ACF6-113CFEF03B16Q40604690-25E177A9-A3D2-4466-BEA2-9780CDBB2553Q41150634-00A8BB6B-EAF6-4626-AFC5-3907D67392E9Q41496862-EBF5108C-C0DB-4287-B7BB-8EA89C323F99Q42532373-E0A36762-B857-45D2-9EED-D357675C458DQ45737539-138C0E74-7487-425D-9DBE-377A7A6948B1Q47400891-973F73AA-D3B6-419E-8579-853C266795F4Q50125448-23938D99-4B6C-4206-B874-0B5CB7084B1CQ50730161-9C64F409-D2C2-4F2F-AC8C-5E7DE6B95938Q50957095-19A27E2D-AAE3-4F78-9D33-8E2F521475EEQ51257285-29012744-4DEA-4174-9565-26295CD301B5Q53017847-4BB15246-4054-4B9E-8694-8342F0D8A25CQ53160804-F530A4FE-4372-4439-B581-BE8F7737CC02Q53394233-5094A908-1BDE-4B72-9BF1-79434125F99AQ54956709-148B69A2-9AD8-4F73-939F-8D218B8E9306
P2860
Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Quality improvement guidelines ...... fusion for hepatic malignancy.
@ast
Quality improvement guidelines ...... fusion for hepatic malignancy.
@en
Quality improvement guidelines ...... fusion for hepatic malignancy.
@nl
type
label
Quality improvement guidelines ...... fusion for hepatic malignancy.
@ast
Quality improvement guidelines ...... fusion for hepatic malignancy.
@en
Quality improvement guidelines ...... fusion for hepatic malignancy.
@nl
prefLabel
Quality improvement guidelines ...... fusion for hepatic malignancy.
@ast
Quality improvement guidelines ...... fusion for hepatic malignancy.
@en
Quality improvement guidelines ...... fusion for hepatic malignancy.
@nl
P2093
P1476
Quality improvement guidelines ...... fusion for hepatic malignancy.
@en
P2093
Anne M Covey
Boris Nikolic
Charles W Nutting
Constantinos T Sofocleous
Daniel B Brown
Daniel Y Sze
Society of Interventional Radiology Standards of Practice Committee
Wael E A Saad
P304
P356
10.1016/J.JVIR.2011.11.029
P50
P577
2012-01-30T00:00:00Z